AIAI.TO NETRAMARK HOLDINGS INC
$0.68▼ -2.86%
Healthcare
Other
Volume 30.1K
Avg Volume (10D) 21.8K
Key Metrics & Fundamentals
Market Cap
$64.35M
P/E Ratio
–
Div Yield
–%
52W Range
0.59 - 1.65
% vs 50 MA
-8.31%
% vs 200 MA
-25.36%
RSI-14
47.1
MACD Histogram
+0.0100
Beta (1Y vs SPY)
0.35
Free Cash Flow
-$1.34M
Gross Rev
$10,582
Gross Profit
$10,582
EBITDA
-$2.19M
COGS
–
Operating Exp
$2.20M
Operating Income
-$2.19M
EBIT
-$2.19M
Pretax Income
-$2.19M
Net Income
-$2.19M
EPS (Diluted)
-0.02
Price & Volume History
Loading chart…
Recent News
Peer-Reviewed Study Published in MDPI’s AI Journal Shows NetraAI Uncovers Clinical Trial Signals Missed by Conventional AI and Foundation Models
GlobeNewswire · Sep 10, 2026 11:00 AM
NetraMark Appoints Former Global Atlantic Investment Office President and Scotiabank U.S. CEO Kevin Felix as Strategic Advisor
GlobeNewswire · Sep 8, 2026 11:00 AM
NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier
GlobeNewswire · Sep 1, 2026 11:00 AM
NetraMark to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Aug 27, 2026 11:00 AM
NetraMark Corporate Update Highlights Record C$3.4 Million in Fiscal 2026 Contract Bookings, Up 645% from Previous Annual High
GlobeNewswire · Aug 20, 2026 11:00 AM
NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness
GlobeNewswire · Jul 13, 2026 11:00 AM
NetraMark Up 11% as It Signs a New Contract To Analyze Phase 2 Neurodegeneration Trial Data
MT Newswires · Jul 9, 2026 4:46 PM
NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner
GlobeNewswire · Jul 9, 2026 11:00 AM
NetraMark to Perform AI-Assisted Analysis of Clinical Trial Data For Biopharm Company
MT Newswires · Jun 29, 2026 5:29 PM
NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company
GlobeNewswire · Jun 29, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
Mar 2026
See AIAI.TO's money flow as a full page
Social Sentiment
No Reddit posts found for AIAI.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.